Search research articles
Contact Us
Filters
Showing results (41-50 of 226) with videos related to
Page
of 23
Sort By:
Lancet (London, England)
|
February 19, 2008
Efficacy and safety of the weight-loss drug rimonabant
Jean-Pierre Després, Luc Van Gaal, Xavier Pi-Sunyer, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
August 16, 2003
Cholecystokinin and stomach distension combine to reduce food intake in humans
Harry R Kissileff, Julie C Carretta, Allan Geliebter, et al.
Obesity Surgery
|
September 30, 2008
Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?
Mousumi Bose, Blanca Oliván, Julio Teixeira, et al.
Physiological Reports
|
November 29, 2017
Validation of whole room indirect calorimeters: refinement of current methodologies
Russell Rising, Thomas Foerster, Avigdor D Arad, et al.
Postgraduate Medicine
|
July 9, 2016
Impact of lorcaserin on glycemic control in overweight and obese patients with type 2 diabetes: analysis of week 52 responders and nonresponders
Xavier Pi-Sunyer, William Shanahan, Randi Fain, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
|
August 24, 2006
Incretins, diabetes, and bariatric surgery: a review
Rachel Fetner, James McGinty, Colleen Russell, et al.
Nutrition (Burbank, Los Angeles County, Calif.)
|
March 3, 2004
Effect of oral glucosamine sulfate on serum leptin levels in human subjects
Blandine Laferrère, Pilar García-Lorda, Colleen D Russell, et al.
Obesity Surgery
|
July 5, 2003
Prevalence of co-morbidities in obese patients before bariatric surgery: effect of race
Luigi Residori, Pilar García-Lorda, Louis Flancbaum, et al.
Diabetes Care
|
February 15, 2008
Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program
Luc Van Gaal, Xavier Pi-Sunyer, Jean-Pierre Després, et al.
Regulatory Toxicology and Pharmacology : RTP
|
May 16, 2017
A 12-week randomized clinical trial investigating the potential for sucralose to affect glucose homeostasis
V Lee Grotz, Xavier Pi-Sunyer, Daniel Porte, et al.
Page
of 23
Search research articles
Search
Showing results (41-50 of 226) with videos related to
Sort By:
Page
of 23
Lancet (London, England)
|
February 19, 2008
Efficacy and safety of the weight-loss drug rimonabant
Jean-Pierre Després, Luc Van Gaal, Xavier Pi-Sunyer, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
August 16, 2003
Cholecystokinin and stomach distension combine to reduce food intake in humans
Harry R Kissileff, Julie C Carretta, Allan Geliebter, et al.
Obesity Surgery
|
September 30, 2008
Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?
Mousumi Bose, Blanca Oliván, Julio Teixeira, et al.
Physiological Reports
|
November 29, 2017
Validation of whole room indirect calorimeters: refinement of current methodologies
Russell Rising, Thomas Foerster, Avigdor D Arad, et al.
Postgraduate Medicine
|
July 9, 2016
Impact of lorcaserin on glycemic control in overweight and obese patients with type 2 diabetes: analysis of week 52 responders and nonresponders
Xavier Pi-Sunyer, William Shanahan, Randi Fain, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
|
August 24, 2006
Incretins, diabetes, and bariatric surgery: a review
Rachel Fetner, James McGinty, Colleen Russell, et al.
Nutrition (Burbank, Los Angeles County, Calif.)
|
March 3, 2004
Effect of oral glucosamine sulfate on serum leptin levels in human subjects
Blandine Laferrère, Pilar García-Lorda, Colleen D Russell, et al.
Obesity Surgery
|
July 5, 2003
Prevalence of co-morbidities in obese patients before bariatric surgery: effect of race
Luigi Residori, Pilar García-Lorda, Louis Flancbaum, et al.
Diabetes Care
|
February 15, 2008
Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program
Luc Van Gaal, Xavier Pi-Sunyer, Jean-Pierre Després, et al.
Regulatory Toxicology and Pharmacology : RTP
|
May 16, 2017
A 12-week randomized clinical trial investigating the potential for sucralose to affect glucose homeostasis
V Lee Grotz, Xavier Pi-Sunyer, Daniel Porte, et al.
Page
of 23